Background: Interbody spinal fusion is a common surgical treatment for degenerative, traumatic, and deformity-related spinal pathologies. Despite advances in cage geometry and fixation strategies that improve alignment and early stability, reliable fusion remains limited by the mechanical and biological constraints of conventional interbody implant materials. Traditional titanium and polymer-based cages often fail to optimally balance load sharing, osteointegration, and biological activity within the mechanically demanding interbody environment. This narrative review examines the development and translational potential of 3D-printed interbody fusion devices, with emphasis on how additive manufacturing enables the integration of mechanical performance with biologically active scaffold design. Methods: A thorough literature review was performed to evaluate the evolution, design principles, material properties, and translational outcomes of three-dimensional (3D)-printed interbody fusion devices. Results: Additive manufacturing enables precise control over implant architecture, allowing for the fabrication of porous, lattice-based cages with tunable stiffness, optimized load sharing, and enhanced bone–implant integration. Preclinical and early clinical studies suggest that 3D-printed porous titanium cages may reduce subsidence, promote osteointegration, and improve fusion-related outcomes compared with conventional designs. Emerging evidence indicates that scaffold porosity, surface microtopography, and bioactive coatings influence macrophage polarization, angiogenesis, and osteogenic signaling. Polymeric and composite constructs, particularly hybrid designs incorporating surface functionalization, represent promising adjuncts, though clinical evidence remains limited. Conclusions: Three-dimensional printing represents a paradigm shift in interbody fusion device design. Continued translational research and longer-term clinical follow-up are required to validate efficacy and guide widespread clinical adoption.
Introduction: Orthopaedic Surgery remains one of the most competitive medical specialties to successfully match into. Historically, the United States Medical Licensing Examination Step 1 score was a major determinant of match success. Since its conversion to pass/fail status in January 2022, uncertainty has emerged regarding how programs mentor and advise applicants. The purpose of this study was to examine the changes in Orthopaedic Surgery applicant characteristics before the transition from a scored examination (2017-2022) to a pass/fail examination (2023-2025). Methods: The authors accessed the Texas Seeking Transparency in Application to Residency survey database, which contains survey information from graduating medical students nationwide regarding residency application characteristics. Characteristics of matched versus unmatched applicants between 2017 to 2022 and 2023 to 2025 were compared. Results: A total of 1,652 Orthopaedic Surgery applicants responded to the survey from 2017 to 2025 (data collected in May 2025). Since the incorporation of a pass/fail Step 1, Step 2 scores and research productivity has increased, volunteerism has decreased, and other academic metrics have remained unchanged. Conclusions: Applicants demonstrated shifts in characteristics without a corresponding change in match rates. From 2023 to 2025, applicants bolstered Step 2 performance and research output as primary differentiators in the absence of a numerical Step 1 score. Traditional academic markers such as class rank, clerkship performance, and Alpha Omega Alpha membership remained stable, while volunteer and leadership involvement declined moderately over the same period. These findings provide evidence-based guidance for navigating the Orthopaedic Surgery selection process in the postnumerical Step 1 era.